Turmeric Extract Suppresses Microglia Activation and Cytokine Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Alzheimer's disease are inadequate in addressing the progression of the disease, particularly in suppressing the activation of microglia and the production of pro-inflammatory cytokines such as PGE2, TNF-α, and IL-1β induced by amyloid β peptides.
Innovation Solution
A composition comprising a turmeric-derived ingredient, specifically a water-soluble turmeric extract or the compounds termeronol A and termeronol B, which are used to treat, prevent, or ameliorate Alzheimer's disease by suppressing microglia activation and the production of PGE2, TNF-α, and IL-1β.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If amyloid β peptide accumulates in the brain, then Alzheimer's disease pathology develops, but microglia activation and production of pro-inflammatory cytokines (PGE2, TNF-α, IL-1β) are induced which accelerate disease progression
Solution Approach 1:
The patent applies this principle by using curcumin, a compound derived from turmeric, to convert the harmful effects of microglia activation and cytokine production into beneficial anti-inflammatory and neuroprotective effects. Curcumin suppresses the excessive activation of microglia and reduces the production of pro-inflammatory cytokines (PGE2, TNF-α, IL-1β) that are harmful in Alzheimer's disease, while potentially harnessing moderate microglial activity for beneficial neuroprotective functions.
Solution Approach 2:
The patent applies this principle by introducing curcumin as an intermediary substance that mediates between the amyloid β peptide pathology and the microglial response. Curcumin acts as a mediator that modulates the interaction between amyloid β peptides and microglia, reducing the harmful inflammatory cascade while maintaining beneficial neuroprotective mechanisms.
2Reliability
If current Alzheimer's disease treatments are used, then some symptomatic relief may be achieved, but they are inadequate in suppressing microglia activation and cytokine production which drive disease progression
Solution Approach 1:
The patent applies this principle by utilizing curcumin's multi-functional properties to address multiple aspects of Alzheimer's disease pathology simultaneously. Curcumin exhibits antioxidant, anti-inflammatory, neuroprotective, and amyloid-aggregation-inhibiting activities, making it a universal treatment that can suppress microglia activation, reduce cytokine production (PGE2, TNF-α, IL-1β), and protect neurons from damage through multiple mechanisms of action.
Data Source
AI summary
This invention provides a composition comprising, as an active ingredient, a turmeric-derived ingredient, which is useful for treatment, prevention, or amelioration of Alzheimer's disease. This invention relates to a composition for treatment of Alzheimer's disease, a composition for suppression of brain nerve cell death, a composition for suppression of microglia activation induced by amyloid β peptide, or a composition for suppression of PGE2, TNF-α, or IL-1β production induced by amyloid β peptide comprising, as an active ingredient, a turmeric extract extracted with at least one extraction solvent selected from water and a hydrophilic organic solvent or at least one of termeronol A and termeronol B.